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Sirs: Amyotrophic lateral sclerosis
(ALS) is a neurodegenerative dis-
ease primarily affecting cortical
and spinal motor neurons. There
have been several previous popu-
lation studies, reporting inci-
dences between 0.44 and 3.2 per
100,000 person-years [1, 2].
As a preliminary step in estab-
lishing a population register for
ALS in South-East England, we have
identified all prevalent cases in the
London Boroughs of Lambeth,
Southwark and Lewisham (LSL)
between 1 January 1997 and 31 July
2004. Cases were identified from
multiple sources to ensure ascer-
tainment was as complete as possi-
ble, but it is important to recognise
that this register covers a relatively
small population, with a high rate of
migration in and out of the area.
Seventy-three individuals with
ALS were identified, of whom 56
were newly diagnosed (23 female,
33 male). Crude incidence was
1.20 per 100,000 person-years
and prevalence 4.06 per 100,000
(Table 1). For England and Wales,
the projected age-adjusted inci-
dence rate was 1.66 per 100,000
person-years (95% CI 1.30–2.03),
(females 1.34 (95% CI 0.95–1.72),
males 2.04 (95% CI 1.50–2.58)).
The cumulative lifetime risk of
ALS in LSL was 0.15% for males
and 0.08% for females by age 75,
(for comparison, it ranges as high
as 0.43% by age 90 in the Irish
register) (Table 2). The median
age of onset was 63 years (males
59.7, females 66.8). Sixty individ-
uals described themselves as
White (83%), 11 Black (15%), one
Asian (1%), and one declined. For
comparison, 25% of the LSL pop-
ulation is Black and 4% Asian
according to the 2001 census[3]. A
binomial test for observing 11 or
fewer events out of 73 when the
event probability is 0.25 has
p=0.03, suggesting ALS may be
less common in those with African
ancestry.
To standardize the clinical
definition of ALS, the World Fed-
eration of Neurology (WFN) has
devised and subsequently revised
diagnostic criteria. To examine the
effect of this on incidence and
prevalence rates, we used three
alternative case definitions: the
original WFN criteria (El Escori-
al), the revised WFN criteria, and
only cases classified as clinically
probable or definite by the original
criteria [4, 5]. Not surprisingly, we
found nearly two-fold variation
in the calculated rates, with the
lowest when including only prob-
able and definite cases, and the
highest when the original criteria
were used (Table 1). The seven-
fold variation in worldwide inci-
dence may therefore partly be
explained by the inclusion meth-
ods of different studies, even
though most use WFN criteria.
Our incidence rates are within
previously reported ranges, but are
at the lower end for most large
studies, as can also be seen from
the lifetime cumulative risk rates.
In addition, in the Italian and Irish
registers, the risk continues to
climb with age, whereas in our
data, this is not seen for those aged
85 years or over. This reflects the
size of this register and the popu-
lation structure in LSL, for exam-
ple having only 5% ‘‘elderly’’
residents compared with 7.6% for
the national average3. There are
fewer cases to ascertain, under-
ascertainment is more likely, and
even with complete ascertainment,
rates depend on population struc-
ture [6]. (Table 2)
Comparative studies using large
scale population registers are nec-
essary to determine the true varia-
tion in the worldwide incidence of
ALS, to confirm if the lifetime risk
continues to increase with age as
suggested by the Irish and Italian
data, and to explore in a larger
sample the possible lower risk for
those with African ancestry that we
have identified. To this end, it is
timely that there is now a European
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initiative to pool epidemiological
resources, EURALS. The South-
East London register will be ex-
panded to include other regions of
South-East England,with the aimof
establishing a comprehensive reg-
ister for the whole UK.
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Table 2 The cumulative lifetime risk of ALS estimated using the cumulative distribution function of an exponential distribution, and expressed as a percentage. The
Italian data are calculated from the Piemonte and Valle d’Aosta register; the Irish risk is calculated from data kindly provided by Drs Bryan Traynor and Orla Hardiman
By Age Italy Ireland LSL
Male risk (%) Female risk (%) Male risk (%) Female risk (%) Male risk (%) Female risk (%)
20 0.00 0.00 0.00 0.00 0.00 0.00
25 0.00 0.00 0.00 0.00 0.00 0.00
30 0.00 0.00 0.00 0.00 0.00 0.00
35 0.00 0.00 0.00 0.00 0.00 0.00
40 0.01 0.00 0.01 0.00 0.00 0.00
45 0.01 0.01 0.02 0.01 0.01 0.01
50 0.02 0.02 0.03 0.02 0.02 0.01
55 0.03 0.03 0.05 0.03 0.03 0.01
60 0.07 0.04 0.09 0.05 0.06 0.01
65 0.11 0.07 0.14 0.08 0.08 0.03
70 0.16 0.11 0.19 0.13 0.11 0.04
75 0.21 0.16 0.25 0.18 0.15 0.08
80 0.27 0.18 0.31 0.22 0.17 0.12
85 0.30 0.19 0.38 0.24 0.17 0.13
90 0.32 0.20 0.43 0.26 0.17 0.13
Table 1 Variation in calculated incidence and prevalence according to how World Federation of Neurology criteria are used for case definition
Criteria used
for case definition
Number of new diagnoses
in study period
Number alive
on 31st July 2004
Crude incidence
(per 100,000 person-years)
Point prevalence
(per 100,000)
Original El Escorial 56 25 1.20 4.06
Revised Airlie House 50 23 1.07 3.74
Probable or Definite Cases only 37 13 0.79 2.11
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